Our team has significant experience discovering, developing and commercializing therapies, particularly for metabolic diseases.
At our core, we are devoted to patients. We are tenacious, data-driven yet creative problem solvers, and we are unapologetic in our efforts to change paradigms. We take a team-based approach to advancing R&D to collectively harness our combined expertise across scientific, drug development, manufacturing and commercial capabilities.
Our scientific advisory board is comprised of metabolic disease experts from around the world who have been engaged in the development of innovative therapies for decades.